Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BUTORPHANOL TARTRAT

Closed
SPE2DP-26-T-3328Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract covers the procurement of Butorphanol Tartrate Injection, a veterinary medication used for pain relief associated with colic in adult horses and yearlings. The product is supplied in 50 mL vials with a concentration of 10 mg/mL and is classified as a DEA Schedule IV controlled substance. Storage requirements specify that the product be kept at controlled room temperature between 20-25°C (68-77°F) and secured in accordance with controlled substance regulations. The vials must be compliant with the latest Medical Marking Standards and adhere to specific Department of Defense technical and quality requirements, including packaging based on MIL-STD-2073-1E. The contract specifies the purchase of 19 vials under the National Stock Number 6509-01-531-0967, with delivery expected within 89 days to the destination point. Inspection and acceptance of the goods occur at the destination, with no quantity variances allowed. The product comes with a 24-month non-extendable shelf life, and the contract incorporates required government identification removal for non-accepted supplies. The solicitation is managed by the Department of Defense Medical Supply Chain Pharmacy FSA, with Zoetis Inc. and other veterinary suppliers noted as potential manufacturers or providers. The contract emphasizes compliance with federal regulations, including FDA oversight and DLA packaging directives, ensuring quality and security throughout the procurement process.

General Info

Procurement of 19 vials Butorphanol Tartrate Injection, DEA Schedule IV, delivered within 89 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, US

Set-Aside

NONE

Documents

(1)

Request for Quotations SPE2DP-26-T-3328

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS
Contacts

Full Description

Show more
BUTORPHANOL TARTRAT
BUTORPHANOL TARTRATE INJECTION, VETERINARY
.
10 MG/ML, 50 ML VIAL; FOR PAIN RELIEF ASSOCIATED WITH
COLIC IN ADULT HORSES AND YEARLINGS;
DEA SCHEDULED DRUG CLASS IV
.
UNIT OF ISSUE: VIAL (VI) OF 50ML.
.
STORE AT CONTROLLED ROOM TEMPERATURE 20-25C (68-77F); SECURED (C-IV)
.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/ .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
ZOETIS INC. 0M1P3 P/N 10009984 ZOETIS INC. 0M1P3 P/N NDC54771-2033-20 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 029088 PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-803-7090 MERCK SHARP & DOHME LLC 6B2S4 P/N 017070 MWI VETERINARY SUPPLY, INC. 1VLG2 P/N NDC67185-0722-66
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3328
SECTION B
PR: 7016722190 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016722190 0001 VI 19.000
NSN/MATERIAL:6509015310967
DELIVERY (IN DAYS):0089
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-531-0967 Quantity: 19 VI Purchase Request: 7016722190QTY: 19 Delivery: 89 days ADO